Medpace Holdings Inc vs Western Alliance Bancorporation — how do they compare? Medpace Holdings Inc trades at $609.54 (market cap $16.90B), while Western Alliance Bancorporation trades at $81.46 (market cap $8.89B). The key difference: Medpace Holdings Inc is the larger of the two by market cap, and Western Alliance Bancorporation pays a 2.06% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | WAL | |
|---|---|---|
Market Cap | $16.90B | $8.89B |
Sector | Technology | Financials |
52-Week High | $620.59 | $96.08 |
52-Week Low | $393.42 | $66.70 |
Enterprise Value | $16.52B | — |
Dividend Yield | — | 2.06% |
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →